The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial
Abstract
Background—: Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) patients with heart failure and preserved left ventricular ejection fraction assigned to spironolactone did not achieve a significant reduction in the primary composite outcome (time to cardiovascular death, aborted cardiac arrest, or hospitalization for management of heart failure) compared with patients receiving placebo. In a post hoc analysis, an ≈4-fold difference was identified in this composite event rate between the 1678 patients randomized from Russia and Georgia compared with the 1767 enrolled from the United States, Canada, Brazil, and Argentina (the Americas). Methods and Results—: To better understand this regional difference in clinical outcomes, demographic characteristics of these populations and their responses to spironolactone were explored. Patients from Russia/Georgia were younger, had less atrial fibrillation and diabetes mellitus, but were more likely to have had prior myocardial infarction or a hospitalization for heart failure. Russia/Georgia patients also had lower left ventricular ejection fraction and creatinine but higher diastolic blood pressure (all P <0.001). Hyperkalemia and doubling of creatinine were more likely and hypokalemia was less likely in patients receiving spironolactone in the Americas with no significant treatment effects in Russia/Georgia. All clinical event rates were markedly lower in Russia/Georgia, and there was no detectable impact of spironolactone on any outcomes. In contrast, in the Americas, the rates of the primary outcome, cardiovascular death, and hospitalization for heart failure were significantly reduced by spironolactone. Conclusions—: This post hoc analysis demonstrated greater potassium and creatinine changes and possible clinical benefits with spironolactone in patients with heart failure and preserved ejection fraction from the Americas. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00094302.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
Owan, T. E., Hodge, D. O., Herges, R. M., Jacobsen, S. J., Roger, V. L., & Redfield, M. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052256 · Cited by 4,191
Redfield, M. M., Jacobsen, S. J., Burnett, J. C., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 3,004
Yusuf, S., Pfeffer, M. A., Swedberg, K., Granger, C. B., Held, P., McMurray, J. J., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14285-7 · Cited by 2,994
Self-citationSpironolactone for heart failure with preserved ejection fraction
Pitt, B., Pfeffer, M. A., Assmann, S. F., Boineau, R., Anand, I. S., Claggett, B., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1313731 · Cited by 2,809
Self-citationOutcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
Bhatia, R. S., Tu, J. V., Lee, D. S., Austin, P. C., Fang, J., Haouzi, A., Gong, Y., & Liu, P. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051530 · Cited by 1,967
Irbesartan in patients with heart failure and preserved ejection fraction
Massie, B. M., Carson, P. E., McMurray, J. J., Komajda, M., McKelvie, R., Zile, M. R., Anderson, S., Donovan, M., Iverson, E., Staiger, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805450 · Cited by 1,960
Subgroup analysis and other (mis)uses of baseline data in clinical trials
Assmann, S. F., Pocock, S. J., Enos, L. E., & Kasten, L. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02039-0 · Cited by 1,167
Self-citationHeart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Borlaug, B. A., & Paulus, W. J. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq426 · Cited by 1,093
Yusuf, S. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010097038 · Cited by 1,014
Glover, J. W. (2010) · Cited by 917
Steinberg, B. A., Zhao, X., Heidenreich, P. A., Peterson, E. D., Bhatt, D. L., Cannon, C. P., Hernandez, A. F., & Fonarow, G. C. (2012) · Circulation · doi:10.1161/circulationaha.111.080770 · Cited by 775
Aurigemma, G. P., & Gaasch, W. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp022709 · Cited by 764
Ather, S., Chan, W., Bozkurt, B., Aguilar, D., Ramasubbu, K., Zachariah, A. A., Wehrens, X. H. T., & Deswal, A. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.040 · Cited by 693
Solomon, S. D., Dobson, J., Pocock, S., Skali, H., McMurray, J. J. V., Granger, C. B., Yusuf, S., Swedberg, K., Young, J. B., Michelson, E. L., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.696906 · Cited by 681
Self-citationThe Challenge of Subgroup Analyses — Reporting without Distorting
Lagakos, S. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068070 · Cited by 504
United States Life Tables, 2019.
Arias, E., & Xu, J. (2022) · PubMed · Cited by 479
Yusuf, S., Pfeffer, Swedberg, K. B., Granger, C. B., Held, P. H., McMurray, J. J. V., Michelson, E. L., Olofsson, B., & Östergren, J. (2003) · Cited by 431
Developing Therapies for Heart Failure With Preserved Ejection Fraction
Butler, J., Fonarow, G. C., Zile, M. R., Lam, C. S., Roessig, L., Schelbert, E. B., Shah, S. J., Ahmed, A., Bonow, R. O., Cleland, J. G. F., et al. (2014) · JACC: Heart Failure · doi:10.1016/j.jchf.2013.10.006 · Cited by 324
Self-citationDesai, A. S., Lewis, E. F., Li, R., Solomon, S. D., Assmann, S. F., Boineau, R., Clausell, N., Diaz, R., Fleg, J. L., Gordeev, I., et al. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.09.007 · Cited by 274
Self-citationVardeny, O., Wu, D. H., Desai, A., Rossignol, P., Zannad, F., Pitt, B., & Solomon, S. D. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.048 · Cited by 272
Self-citationVardeny, O., Claggett, B., Anand, I., Rossignol, P., Desai, A. S., Zannad, F., Pitt, B., & Solomon, S. D. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001104 · Cited by 209
Self-citationBurke, M. A., Katz, D. H., Beussink, L., Selvaraj, S., Gupta, D. K., Fox, J., Chakrabarti, S., Sauer, A. J., Rich, J. D., Freed, B. H., et al. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.000854 · Cited by 209
Self-citationCampbell, R. T., Jhund, P. S., Castagno, D., Hawkins, N. M., Petrie, M. C., & McMurray, J. J. V. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.04.064 · Cited by 179
Blair, J. E. A., Zannad, F., Konstam, M. A., Cook, T., Traver, B., Burnett, J. C., Grinfeld, L., Krasa, H., Maggioni, A. P., Orlandi, C., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.056 · Cited by 173
Incidence and Predictors of Hyperkalemia in Patients With Heart Failure
Desai, A. S., Swedberg, K., McMurray, J. J. V., Granger, C. B., Yusuf, S., Young, J. B., Dunlap, M. E., Solomon, S. D., Hainer, J. W., Olofsson, B., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.067 · Cited by 170
Freemantle, N. (2001) · BMJ · doi:10.1136/bmj.322.7292.989 · Cited by 169
Ahmed, A., Allman, R. M., Fonarow, G. C., Love, T. E., Zannad, F., Dell'Italia, L. J., White, M., & Gheorghiade, M. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.12.001 · Cited by 166
de Werf, F. V. (1995) · JAMA · doi:10.1001/jama.273.20.1586 · Cited by 164
Rossignol, P., Cleland, J. G. F., Bhandari, S., Tala, S., Gustafsson, F., Fay, R., Lamiral, Z., Dobre, D., Pitt, B., & Zannad, F. (2012) · Circulation · doi:10.1161/circulationaha.111.028282 · Cited by 158
Self-citationBello, N. A., Claggett, B., Desai, A. S., McMurray, J. J. V., Granger, C. B., Yusuf, S., Swedberg, K., Pfeffer, M. A., & Solomon, S. D. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.113.001281 · Cited by 147
Self-citationSubgroup analyses in therapeutic cardiovascular clinical trials: Are most of them misleading?
Hernández, A. V., Boersma, E., Murray, G. D., Habbema, J. D. F., & Steyerberg, E. W. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.020 · Cited by 131
Eapen, Z. J., Reed, S. D., Li, Y., Kociol, R. D., Armstrong, P. W., Starling, R. C., McMurray, J. J. V., Massie, B. M., Swedberg, K. B., Ezekowitz, J. A., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.000265 · Cited by 124
Wedel, H., DeMets, D. L., DEEDWANIA, P. C., Fagerberg, B., Goldstein, S., Gottlieb, S. S., Hjalmarson, Å. C., Kjekshus, J., Waagstein, F., & Wikstrand, J. (2001) · American Heart Journal · doi:10.1067/mhj.2001.117600 · Cited by 111
Principles From Clinical Trials Relevant to Clinical Practice: Part I
Califf, R. M., & DeMets, D. L. (2002) · Circulation · doi:10.1161/01.cir.0000023260.78078.bb · Cited by 108
Contemporary Prevalence and Correlates of Incident Heart Failure with Preserved Ejection Fraction
Gurwitz, J. H., Magid, D. J., Smith, D. H., Goldberg, R. J., McManus, D. D., Allen, L. A., Saczynski, J. S., Thorp, M. L., Hsu, G., Sung, S. H., et al. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.10.022 · Cited by 95
Diagnosis and Management of Heart Failure with Preserved Ejection Fraction: 10 Key Lessons
Oktay, A. A., & Shah, S. J. (2014) · Current Cardiology Reviews · doi:10.2174/1573403x09666131117131217 · Cited by 94
Self-citationInternational differences in treatment effect: do they really exist and why?†
Pocock, S., Calvo, G., Marrugat, J., Prasad, K., Tavazzi, L., Wallentin, L. C., Zannad, F. M., & Garcia, A. A. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht071 · Cited by 66
Gheorghiade, M., Vaduganathan, M., Greene, S. J., Mentz, R. J., Adams, K. F., Anker, S. D., Arnold, M., Baschiera, F., Cleland, J. G. F., Cotter, G., et al. (2012) · Heart Failure Reviews · doi:10.1007/s10741-012-9361-8 · Cited by 57
Implications of geographical variation on clinical outcomes of cardiovascular trials
Mentz, R. J., Kaski, J. C., Dan, G., Goldstein, S., Stockbridge, N., Alonso-García, Á., Ruilope, L. M., Martínez, F. A., Zannad, F. M., Pitt, B., et al. (2012) · American Heart Journal · doi:10.1016/j.ahj.2012.06.006 · Cited by 54
Self-citationRisk Following Hospitalization in Stable Chronic Systolic Heart Failure
Abrahamsson, P., Swedberg, K. B., BORER, J. S., Böhm, M., Køber, L., Michel Komajda, N., Lloyd, S. M., Metra, M., Tavazzi, L., & Ford, I. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft032 · Cited by 49
Defining Diastolic Heart Failure and Identifying Effective Therapies
Cleland, J. G. F., & Pellicori, P. (2013) · JAMA · doi:10.1001/jama.2013.1569 · Cited by 41
Massie, B. M., Cleland, J. G. F., Armstrong, P. W., Packer, M., Poole-Wilson, P. A., & Lars, R. (1998) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(98)90502-4 · Cited by 40
Rossignol, P., Dobre, D., Gregory, D., Massaro, J. M., Kiernan, M., Konstam, M. A., & Zannad, F. M. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.02.034 · Cited by 31
Principles From Clinical Trials Relevant to Clinical Practice: Part II
Califf, R. M., & DeMets, D. L. (2002) · Circulation · doi:10.1161/01.cir.0000023218.39412.32 · Cited by 29
Simes, R. J., O’Connell, R. L., Aylward, P. E., Varshavsky, S., Díaz, R., Wilcox, R. G., Armstrong, P. W., Granger, C. B., French, J. K., de Werf, F. V., et al. (2010) · American Heart Journal · doi:10.1016/j.ahj.2009.12.044 · Cited by 27
DOMANSKI, M. J., Antman, E. M., McKinlay, S. M., Varshavsky, S., Platonov, P. G., Assmann, S. F., & Norman, J. E. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2004.08.005 · Cited by 21
Self-citationHeart Failure and Preserved Left Ventricular Function: Long Term Clinical Outcome
Gotsman, I., Zwas, D. R., Lotan, C., & Keren, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041022 · Cited by 20
Fiuzat, M., & Califf, R. M. (2011) · Heart Failure Clinics · doi:10.1016/j.hfc.2011.06.004 · Cited by 8
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418
Metadata
- Authors
- Pfeffer, M. A., Claggett, B., Assmann, S. F., Boineau, R., Anand, I. S., Clausell, N., Desai, A. S., Diaz, R., Fleg, J. L., Gordeev, I., Heitner, J. F., Lewis, E. F., O’Meara, E., Rouleau, J.-L., Probstfield, J. L., Shaburishvili, T., Shah, S. J., Solomon, S. D., Sweitzer, N. K., McKinlay, S. M., & Pitt, B.
- Venue
- Circulation
- Published
- 2015-01-06
- Volume
- 131
- Issue
- 1
- Pages
- 34-42
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2104209472
- Cited by
- 1,065
- References
- 52
- FWCI
- 42.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.